<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01218763</url>
  </required_header>
  <id_info>
    <org_study_id>ITHO02</org_study_id>
    <nct_id>NCT01218763</nct_id>
  </id_info>
  <brief_title>CANadian Clinical Evaluation of SpiderFlash Arrhythmia DETECTion in SpiderFlash™ Device</brief_title>
  <acronym>CAN-DETECT</acronym>
  <official_title>CANadian Clinical Evaluation of the Automatic Arrhythmia DETECTion in SpiderFlash™ Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sorin Group Canada</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sorin Group Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical investigation is a prospective, non-randomized, multi-center pivotal trial.

      This trial aims to validate the automatic detection features provided by the external
      long-duration SpiderFlash-t™ Event recorder coupled with its analyser EventScope™, and to
      assess the performances of the Mode Switch function provided by Sorin Group Implantable
      Cardioverter-Defibrillators (ICDs).

      This trial is being performed first in order to demonstrate the ventricular tachycardia (VT)/
      ventricular fibrillation (VF) sensitivity of the automatic VT/VF detection function of the
      EventScope™ software.

      Patients will be implanted with an ICD from Sorin Group, with PARAD+ arrhythmia detection
      enabled and Mode Switch (MS) algorithms activated in all patients.

      Arrhythmic events will be documented over a period of 6 to 8 weeks for each patient.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>VT/VF sensitivity</measure>
    <time_frame>2 years</time_frame>
    <description>The primary purpose of this study is to evaluate the performance of the automatic detection of ventricular tachycardia and ventricular fibrillation (VT/VF) by the EventScope™ analyzer found in the Holter monitor SpiderFlash-t™. In order to validate this objective we will use the arrhythmia data collected in the memory storage found in the Sorin Group DR and CRT ICDs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AF sensitivity</measure>
    <time_frame>2 years</time_frame>
    <description>The main secondary objective of this study is to evaluate the detection of atrial fibrillation by the Mode Switch algorithm found in the Sorin Group defibrillators. However, as SpiderFlash-t has only been validated on patients with spontaneous rhythm, in order to achieve this objective we will use the AF events detected by the EventScope™ in patients presenting with a spontaneous rhythm. SafeR mode, programmed in DR devices, will permit preservation of such rhythm.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">101</enrollment>
  <condition>Arrhythmias, Cardiac</condition>
  <arm_group>
    <arm_group_label>ICD patients</arm_group_label>
    <description>Candidates may come from the investigator's general population, who require DR ICD or CRT-D therapy for primary or secondary ICD indication and meet all study eligibility criteria</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Candidates may come from the investigator's general population, who require DR ICD or CRT-D
        therapy for primary or secondary ICD indication and meet all study eligibility criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients already implanted with an OVATIO DR or CRT-D device may be included in the study
        if they presented with at least one clinical VT/VF event at the follow-up visit preceding
        the enrolment.

        ICD or CRT-D device upgrading or replacement are allowed but under the condition that
        existing bipolar RV sensing/pacing lead and/or defibrillation lead and/or LV pacing lead
        (where applicable) are not of poor or questionable integrity.

        Patients with implanted pacemakers may be included in the study only if the pacemaker is to
        be explanted or otherwise disabled prior to implanting the ICD or CRT-D system, to avoid
        any potential pacemaker-ICD interactions.

        Patients must comply with all the following criteria in order to be included in the
        CAN-DETECT study:

          1. Patient is eligible for implantation of a dual-chamber ICD or a CRT-D device according
             to current available guidelines for primary or secondary ICD indication .

          2. A stable, optimal (as determined by the enrolling physician) drug regimen

          3. Scheduled for implant of an OVATIO DR Model 6550 or OVATIO CRT 6750 or an equivalent
             device from Sorin Group.

          4. Signed and dated informed consent.

        Exclusion Criteria:

        Any patient complying with any of the following criteria cannot be included in the
        CAN-DETECT study:

          1. Any contraindication for standard cardiac pacing

          2. Any contraindication for ICD therapy

          3. Permanent high-degree AV Block for patients planned for dual-chamber ICD implant only.

          4. Permanent AF for patients planned for dual-chamber ICD implant only.

          5. Abdominal implantation site

          6. Acute myocarditis

          7. Mechanical tricuspid valve

          8. Heart transplant recipient

          9. Already participating in another clinical study

         10. Life expectancy less than 6 months

         11. Inability to understand the purpose of the study or refusal to cooperate

         12. Inability or refusal to provide informed consent

         13. Unavailability for scheduled follow-up at the implanting center

         14. Under guardianship

         15. Age of less than 18 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcio Sturmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital du Sacre-Coeur, Montreal, Qc, Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernard Thibault, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MHI, Montreal, Qc, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grey-Nuns and Royal-Alexandra Hospitals</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6L 5X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sajad Gulamhusein, MD</last_name>
      <phone>780-735-7739</phone>
      <email>sajadgulamhusein@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Diane Beaudette, RN</last_name>
      <phone>780-735-7135</phone>
      <email>dbeaudette@shaw.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Sajad Gulamhusein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Randall Williams, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hotel-Dieu</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine Bergeron, RN</last_name>
      <phone>514 890 8000</phone>
      <phone_ext>12792</phone_ext>
      <email>Martine.Bergeron@crchum.qc.ca</email>
    </contact>
    <contact_backup>
      <last_name>Denise Fournier</last_name>
      <phone>514 890 8000</phone>
      <phone_ext>12795</phone_ext>
      <email>denise.fournier.chum@ssss.gouv.qc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Benoit Coutu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital du Sacre-Coeur</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcio Sturmer, MD</last_name>
      <phone>(514)-338-2222</phone>
      <phone_ext>3722</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Ann Langlois</last_name>
      <phone>(514)-338-2222</phone>
      <phone_ext>3722</phone_ext>
      <email>A-Langlois@crhsc.rtss.qc.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>ICM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHUS</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Ayala-Paredes, MD</last_name>
      <phone>1819 346 1110</phone>
      <phone_ext>14 326</phone_ext>
      <email>Felix.Ayala-Paredes@USherbrooke.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2010</study_first_submitted>
  <study_first_submitted_qc>October 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2010</study_first_posted>
  <last_update_submitted>June 10, 2011</last_update_submitted>
  <last_update_submitted_qc>June 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2011</last_update_posted>
  <responsible_party>
    <name_title>Marcio Sturmer, MD</name_title>
    <organization>Hopital du Sacre-Coeur, Montreal, Quebec</organization>
  </responsible_party>
  <keyword>Cardiac Event recorder</keyword>
  <keyword>Sensitivity</keyword>
  <keyword>Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

